HBsAg Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2A in Chronic Hepatitis B: Long-Term Results of a Global Randomized Controlled Trial

Journal article

Peer reviewed

S.-H. Ahn, P. Marcellin, X. Ma, F. Caruntu, W.Y. Tak, M. Elkhashab, W.-L. Chuang, F. Tabak, R. Mehta, J. Petersen, …

Journal of hepatology, v 64(2), pp S524-S525

2016

Additional Links

21 Record Views

Title: HBsAg Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2A in Chronic Hepatitis B: Long-Term Results of a Global Randomized Controlled Trial
Creators: S.-H. Ahn
P. Marcellin
X. Ma
F. Caruntu
W.Y. Tak
M. Elkhashab
W.-L. Chuang
F. Tabak
R. Mehta
J. Petersen
A. Corsa
E.B. Martins
L.J. Yee
P. Dinh
G. Mani Subramanian
M. Buti
G. Gaeta
G. Papatheodoridis
R. Flisiak
H.L.Y. Chan
Publication Details: Journal of hepatology, v 64(2), pp S524-S525
Publisher: Elsevier
Resource Type: Journal article
Language: English
Academic Unit: Medicine (Graduate)
Web of Science ID: WOS:000398715800109
Other Identifier: 991019167572604721

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Web of Science research areas: Gastroenterology & Hepatology